The alternatives
Mondae scores 70/100 (grade C, ranked #158) on The Verdict Score. Here are the GLP-1 providers we'd weigh against it, scored on the same six-factor rubric. Partners we work with carry a small, fixed edge in where they are listed; the scores themselves are not adjusted.
This shortlist uses nearby positions in our published ranking, with our featured partner shown first. It compares program terms and features; your clinician must assess treatment suitability.
Published by The GLP-1 Verdict
Check dates vary by provider.
The most honest middle of the market: nationwide access, both molecules at one flat, no-surprise price.
CoreAge Rx scores 94/100 to Mondae's 70, and our Mondae vs CoreAge Rx comparison sets the two out factor by factor.
A genuinely flat rate at every dose, four named pharmacies, and a homepage that keeps advertising the twelve-month tier instead.
Lean Meds matches Mondae at 70/100; our full write-up on Lean Meds has the pricing conditions and the caveats in detail.
Names its medical director, prices an oral route below the injection, and publishes three different price sets for the same programs.
Nova matches Mondae at 70/100; our full write-up on Nova has the pricing conditions and the caveats in detail.
A clean product page with a published price, in front of intake funnels that quote different numbers and sell a different program.
Andrew Meds matches Mondae at 70/100; our Andrew Meds review in full has the pricing conditions and the caveats in detail.
Will not name the molecule until it has your address, and then quotes prices its own homepage never mentions.
Oria Meds matches Mondae at 70/100; the full Oria Meds review has the pricing conditions and the caveats in detail.
Names its six dispensing pharmacies and two of its prescribing physicians with NPIs you can check — and sells no month-to-month plan at all, so the advertised “$199/mo average” is $597 charged every twelve weeks.
Pallas Health matches Mondae at 70/100; the full Pallas Health review has the pricing conditions and the caveats in detail.
AltRx advertises compounded semaglutide from $89 and tirzepatide from $149 monthly, with subscription terms and renewal costs to confirm before payment.
altRX matches Mondae at 70/100; the full altRX review has the pricing conditions and the caveats in detail.
See the complete rankings, the alternatives to every provider, A to Z, or head to the comparison hub.
Pricing, states and verification reflect each provider's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Not medical advice; see our disclosure.